Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports)

While survival rates in paediatric acute lymphoblastic leukaemia (ALL) nowadays exceed 90%, systemic ALL relapse, especially after haemopoietic stem cell transplantation (HSCT), is associated with a poor outcome. As there is currently no standardized treatment for this situation, individualized trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Poyer, Fiona, Füreder, Anna, Holter, Wolfgang, Peters, Christina, Boztug, Heidrun, Dworzak, Michael, Engstler, Gernot, Friesenbichler, Waltraud, Köhrer, Stefan, Lüftinger, Roswitha, Ronceray, Leila, Witt, Volker, Pichler, Herbert, Attarbaschi, Andishe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134426/
https://www.ncbi.nlm.nih.gov/pubmed/35646299
http://dx.doi.org/10.1177/20406207221099468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134426/
https://www.ncbi.nlm.nih.gov/pubmed/35646299
http://dx.doi.org/10.1177/20406207221099468

Ejemplares similares